Autoimmune Diseases  >>  Admelog (insulin lispro biosimilar)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Admelog (insulin lispro biosimilar) / Sanofi
SORELLA1, NCT02273180 / 2013-002945-12: Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

Completed
3
507
Japan, US, Europe, RoW
SAR342434, Humalog, Insulin Lispro, Insulin glargine HOE901, Lantus
Sanofi
Type 1 Diabetes Mellitus
12/15
07/16

Download Options